Imf Eye Drop contains Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of bacterial infections of the eye. Moxifloxacin exhibits potent bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, repair, and recombination. This mechanism effectively halts bacterial proliferation, making Imf Eye Drop suitable for managing bacterial conjunctivitis and other superficial ocular infections caused by susceptible strains of gram-positive and gram-negative bacteria. The formulation ensures rapid penetration into ocular tissues, providing effective antimicrobial concentrations at the site of infection. Imf Eye Drop is typically administered as one or two drops into the affected eye(s) every 2 to 4 hours initially, with the frequency gradually reduced as clinical improvement occurs, under the guidance of a healthcare professional. Patients should be advised to avoid contamination of the dropper tip and to complete the full course of therapy even if symptoms improve early, to prevent recurrence and resistance development. Common adverse reactions may include transient eye irritation, burning, or discomfort upon instillation. Use with caution in patients with known hypersensitivity to fluoroquinolones or other components of the formulation. Imf Eye Drop is contraindicated in viral or fungal ocular infections where antibacterial therapy is ineffective.